Drug profile · INN
gallamine triethiodide
FLAXEDIL
gallamine triethiodide (FLAXEDIL) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — gallamine triethiodide
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
gallamine triethiodide (FLAXEDIL) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscle-type nicotinic acetylcholine receptor antagonist
Primary target: Muscle-type nicotinic acetylcholine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is gallamine triethiodide?
gallamine triethiodide (FLAXEDIL) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for gallamine triethiodide?
FLAXEDIL is a marketed brand name for gallamine triethiodide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gallamine triethiodide?
gallamine triethiodide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.